6 "Malignant Melanoma" clinical trials found.

• UPCC 09618: Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma

  The main purpose of this study is to determine the rate of positive sentinel lymph nodes (i.e. the closest ...

  Exact  Phase  Giorgos Karakousis

• 

  KEYMAKER-U02- substudy 02B

  Patients from Penn Medicine's Abramson Cancer Center will be approached for participation.

  
  

  This sub-study is part of a larger ...

  Exact  Phase  Tara Mitchell

• 

  Quality Improvement Assessment for Patient-Centered Community Health Worker Intervention

  The purpose of the IMPaCT Transitions program is to help low-income general medicine patients who have been cared for at ...

  Exact  Phase N/A

• “The Shift Worker’s Microbiome”

  We are looking for healthy males, age 40-59 years old, non-smoking un-medicated who work the "shift-work" schedule (>3 shifts per ...

  Exact  Phase N/A Lavenia M Banas, Rn

• 

  A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects with Primary Focal ...

  Primary FSGS is a progressive disease that causes the kidneys to scar, to leak protein into the urine and may ...

  Exact  Phase 

• 

  An Open-Label Safety and Tolerability Phase 1b Trial of CAN04 A Fully Humanized Anti-IL1RAP Monoclonal Antibody in Combination with Pembrolizumab ...

  This study will consider the safety and effectiveness of a study drug, CAN04, in combination with pembrolizumab, in the treatment ...

  Free text  Phase